The Latest
Vermont Governor Takes the Right Approach to Tobacco Harm Reduction
Gov. Scott should be praised for his commonsense approach to legislating tobacco harm reduction products.
CCAGW Urges Mississippi Legislators to Oppose House Bill 1265
HB 1265 would create unnecessary regulatory barriers to undermine the effectiveness of PBMs in Mississippi.
Price Controls Kill More Than Innovation
Sanders’ pharmaceutical price controls will not only reduce future drug development but also cripple the generics industry.
The IRS Continues to Live Down to its Reputation
If past is prologue, IRS' latest effort to stymie competition among tax preparers will end in user dissatisfaction and lawsuits
CCAGW Urges California Legislators to Oppose Senate Bill 966
SB 966 would create unnecessary regulatory barriers to undermine the effectiveness of pharmaceutical benefit managers (PBMs) in the Golden State.
Lives Hang in the Balance While the FDA Bureaucracy Churns
The government red tape contributing to the backlog of PMTAs has put consumers at risk with illicit products.
Virginia Fights for Affordable, Accessible Broadband
Virginia’s firm stand on BEAD funding serves as a beacon for the states.
CCAGW Urges Senate Homeland Security and Government Affairs Committee to Support S. 2871
S. 2871 would make federal agencies more secure and efficient while reducing costs and duplication.
CCAGW Urges Pennsylvania Legislators to Oppose Senate Bill 1000
SB 1000 creates unnecessary regulatory barriers that will undermine the effectiveness of PBMs in Pennsylvania.
ACP Funding Expiration Will Affect States’ Broadband Rate Regulation
Ending ACP will complicate and delay state efforts to expand affordable internet access.
CCAGW Urges Kansas Legislators to Oppose Amendment to SB 514
The move to amend Substitute for SB 514 will change how the federal 340B drug pricing program operates in the Sunflower State.
FTC Chair Khan Should Focus on Production and Prices Instead of Political Pressure
Mergers should be reviewed based on their benefits to consumers, not pressure from members of Congress.